This study will evaluate the efficacy and safety of UGN-104, a new formulation of UGN-101 (approved in the United States and Israel as JELMYTO [mitomycin] for pyelocalyceal solution), instilled in the upper urinary tract (UUT) of patients with…
- Investigator
- Padraic O'Malley
- Ages
- 18 Years - N/A
- Sexes
- All